CARDIOMETABOLIC SYNDROME: THE IMPACT OF DIABETES, HYPERTENSION, AND OBESITY ON CARDIOVASCULAR DISEASES

Аннотация

Cardiometabolic syndrome is a complex pathological condition characterized by the coexistence of diabetes, hypertension, and obesity, significantly increasing the risk of developing cardiovascular diseases. This article analyzes the pathophysiological mechanisms of cardiometabolic syndrome, including insulin resistance, inflammatory processes, and dyslipidemia, and their impact on heart function. Additionally, strategies for disease prevention and treatment, including lifestyle modifications, pharmacological approaches, and current clinical recommendations, are discussed. The research findings highlight the necessity of developing effective preventive and therapeutic measures against cardiometabolic syndrome. Keywords: cardiometabolic syndrome, diabetes, hypertension, obesity, cardiovascular diseases, insulin resistance, dyslipidemia, inflammation, metabolic disorders, prevention, pharmacotherapy. Кардиометаболический синдром: влияние сахарного диабета, гипертонии и ожирения на сердечно-сосудистые заболевания Мингалиева Шахризода Дилмуродовна Раджабалиева Мохрухсор Амандуллоевна Термезский университет экономики и сервиса, Студенты медицинского факультета Email: mohruhsorrajabaliyeva@gmail.com shahrizodamingaliyeva780gmail.com Аннотация: Кардиометаболический синдром — это комплексное патологическое состояние, характеризующееся сочетанием сахарного диабета, 324 Acumen: International Journal of Multidisciplinary Research Acumen: International Journal of Multidisciplinary Research ISSN: 3060-4745 IF(Impact Factor)10.41 / 2024 Volume 2, Issue 2 гипертонии и ожирения, что значительно повышает риск развития сердечно- сосудистых заболеваний. В данной статье анализируются патофизиологические механизмы кардиометаболического синдрома, включая инсулинорезистентность, воспалительные процессы и дислипидемию, а также их влияние на функцию сердца. Кроме того, рассматриваются стратегии профилактики и лечения данного состояния, включая изменение образа жизни, фармакологические подходы и актуальные клинические рекомендации. Результаты исследования подчеркивают необходимость разработки эффективных профилактических и терапевтических мер против кардиометаболического синдрома. Ключевые слова: кардиометаболический синдром, сахарный диабет, гипертония, ожирение, сердечно-сосудистые заболевания, инсулинорезистентность, дислипидемия, воспаление, метаболические нарушения, профилактика, фармакотерапия. Relevance of the Problem: Cardiometabolic syndrome (CMS) is one of the most pressing global health issues today. The components of this syndrome—diabetes, hypertension, and obesity—affect millions of people worldwide, significantly increasing the risk of developing cardiovascular diseases (CVD). According to the World Health Organization (WHO), CVD remains one of the leading causes of mortality and disability. Modern lifestyle factors such as poor diet, physical inactivity, and stress contribute to the widespread prevalence of cardiometabolic syndrome. Notably, obesity and insulin resistance are also increasing among children and adolescents, posing a serious threat to the health of future generations. Furthermore, cardiometabolic syndrome imposes a substantial economic burden not only on individual patients but also on the entire healthcare system, as treatment costs continue to rise annually. Strengthening preventive measures, ensuring early diagnosis, and developing effective therapeutic approaches are crucial for addressing this issue. Therefore, studying CMS and its relationship with CVD is one of the priority areas of scientific and clinical research today. Pathophysiological Mechanisms: The key pathophysiological mechanisms of cardiometabolic syndrome include insulin resistance, inflammatory processes, and dyslipidemia. These factors have a complex impact on the cardiovascular system, paving the way for atherosclerosis, hypertension, and other heart diseases.Insulin Resistance (IR): As a central pathogenic factor of cardiometabolic syndrome, insulin resistance is characterized by reduced cellular sensitivity to insulin. In this condition: Glucose cannot efficiently enter cells, leading to hyperglycemia. The pancreas compensates by increasing insulin secretion (hyperinsulinemia). Insulin’s effects on 325 Acumen: International Journal of Multidisciplinary Research Acumen: International Journal of Multidisciplinary Research ISSN: 3060-4745 IF(Impact Factor)10.41 / 2024 Volume 2, Issue 2 blood vessel walls are disrupted, leading to endothelial dysfunction, which increases the risk of atherosclerosis and hypertension. Chronic Low-Grade Inflammation: Chronic low-grade inflammation plays a key role in the development of metabolic disorders in cardiometabolic syndrome: In obesity, adipose tissue produces inflammatory mediators. These mediators impair insulin signaling pathways, exacerbating insulin resistance. Chronic inflammation contributes to oxidative stress and endothelial dysfunction, facilitating the onset of cardiovascular disease